The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets

Thrombosis Research

Volumn 129, Issue 4, 2012, Pages

  Nylander, Martina ^a   Osman, Abdimajid ^a   Ramström, Sofia ^a   Åklint, Emma ^a   Larsson, Anders ^b   Lindahl, Tomas L ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood Platelets; PAR1; PAR4; Plasminogen Activator Inhibitor 1; Thrombin; VEGF

Indexed keywords

ENDOSTATIN; MESSENGER RNA; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; VASCULOTROPIN;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; THROMBOCYTE METABOLISM; THROMBOCYTE PRESERVATION; WESTERN BLOTTING;

BLOOD PLATELETS; CELLS, CULTURED; ENDOSTATINS; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; THROMBIN;

EID: 84858333888     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.12.021     Document Type: Article

References (46)

1. S. Offermanns, K.L. Laugwitz, K. Spicher, and G. Schultz G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets Proc Natl Acad Sci U S A 91 1994 504 508
2. L. Ma, R. Perini, W. McKnight, M. Dicay, A. Klein, and M.D. Hollenberg Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets Proc Natl Acad Sci U S A 102 2005 216 220
3. J.E. Italiano Jr., and E.M. Battinelli Selective sorting of alpha-granule proteins J Thromb Haemost 7 Suppl 1 2009 173 176
4. M. Grenegard, K. Vretenbrant-Oberg, M. Nylander, S. Desilets, E.G. Lindstrom, and A. Larsson The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine J Biol Chem 283 2008 18493 18504
5. K. Falker, L. Haglund, P. Gunnarsson, M. Nylander, T.L. Lindahl, and M. Grenegard Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets Biochem J 436 2011 469 480
6. K. Vretenbrant, S. Ramstrom, M. Bjerke, and T.L. Lindahl Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development Thromb Haemost 97 2007 417 424
7. L. Covic, C. Singh, H. Smith, and A. Kuliopulos Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome Thromb Haemost 87 2002 722 727
8. M. Holinstat, B. Voss, M.L. Bilodeau, and H.E. Hamm Protease-activated receptors differentially regulate human platelet activation through a phosphatidic acid-dependent pathway Mol Pharmacol 71 2007 686 694
9. A. Mazharian, S. Roger, E. Berrou, F. Adam, A. Kauskot, and P. Nurden Protease-activating receptor-4 induces full platelet spreading on a fibrinogen matrix: involvement of ERK2 and p38 and Ca2 + mobilization J Biol Chem 282 2007 5478 5487
10. R. Ramachandran, and M.D. Hollenberg Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more Br J Pharmacol 153 Suppl 1 2008 S263 S282
11. I.M. Lang, and R.R. Schleef Calcium-dependent stabilization of type I plasminogen activator inhibitor within platelet alpha-granules J Biol Chem 271 1996 2754 2761
12. J. Chmielewska, M. Ranby, and B. Wiman Evidence for a rapid inhibitor to tissue plasminogen activator in plasma Thromb Res 31 1983 427 436
13. T.L. Lindahl, P.I. Ohlsson, and B. Wiman The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator Biochem J 265 1990 109 113
14. N.A. Booth, L.A. Robbie, A.M. Croll, and B. Bennett Lysis of platelet-rich thrombi: the role of PAI-1 Ann N Y Acad Sci 667 1992 70 80
15. W.P. Fay, D.T. Eitzman, A.D. Shapiro, E.L. Madison, and D. Ginsburg Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms Blood 83 1994 351 356
16. A. Nordenhem, and B. Wiman Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G/5G polymorphism in the PAI-1 gene Scand J Clin Lab Invest 57 1997 453 461
17. L.A. Robbie, B. Bennett, A.M. Croll, P.A. Brown, and N.A. Booth Proteins of the fibrinolytic system in human thrombi Thromb Haemost 75 1996 127 133
18. H.A. Stringer, P. van Swieten, H.F. Heijnen, J.J. Sixma, and H. Pannekoek Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop Arterioscler Thromb Vasc Biol 14 1994 1452 1458
19. H. Brogren, L. Karlsson, M. Andersson, L. Wang, D. Erlinge, and S. Jern Platelets synthesize large amounts of active plasminogen activator inhibitor 1 Blood 104 2004 3943 3948
20. A. Hamsten, B. Wiman, U. de Faire, and M. Blomback Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction N Engl J Med 313 1985 1557 1563
21. J.P. Collet, G. Montalescot, E. Vicaut, A. Ankri, F. Walylo, and C. Lesty Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality Circulation 108 2003 391 394
22. T. Hoekstra, J.M. Geleijnse, E.G. Schouten, and C. Kluft Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk Thromb Haemost 91 2004 861 872
23. T.W. Meade, V. Ruddock, Y. Stirling, R. Chakrabarti, and G.J. Miller Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study Lancet 342 1993 1076 1079
24. A.S. Weyrich, S. Lindemann, N.D. Tolley, L.W. Kraiss, D.A. Dixon, and T.M. Mahoney Change in protein phenotype without a nucleus: translational control in platelets Semin Thromb Hemost 30 2004 491 498
25. S. Lindemann, N.D. Tolley, D.A. Dixon, T.M. McIntyre, S.M. Prescott, and G.A. Zimmerman Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis J Cell Biol 154 2001 485 490
26. A.S. Weyrich, D.A. Dixon, R. Pabla, M.R. Elstad, T.M. McIntyre, and S.M. Prescott Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets Proc Natl Acad Sci U S A 95 1998 5556 5561
27. J. Kisucka, C.E. Butterfield, D.G. Duda, S.C. Eichenberger, S. Saffaripour, and J. Ware Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage Proc Natl Acad Sci U S A 103 2006 855 860
28. T. Browder, J. Folkman, and S. Pirie-Shepherd The hemostatic system as a regulator of angiogenesis J Biol Chem 275 2000 1521 1524
29. G.J. Gasic Role of plasma, platelets, and endothelial cells in tumor metastasis Cancer Metastasis Rev 3 1984 99 114
30. G.F. Nash, D.C. Walsh, and A.K. Kakkar The role of the coagulation system in tumour angiogenesis Lancet Oncol 2 2001 608 613
31. H.M. Verheul, and H.M. Pinedo Tumor Growth: A Putative Role for Platelets Oncologist 3 1998 II
32. P. Mehta Potential role of platelets in the pathogenesis of tumor metastasis Blood 63 1984 55 63
33. J.E. Italiano Jr., J.L. Richardson, S. Patel-Hett, E. Battinelli, A. Zaslavsky, and S. Short Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released Blood 111 2008 1227 1233
34. M. Chatterjee, Z. Huang, W. Zhang, L. Jiang, K. Hultenby, and L. Zhu Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli Blood 117 2011 3907 3911
35. D.J. Angiolillo, D. Capodanno, and S. Goto Platelet thrombin receptor antagonism and atherothrombosis Eur Heart J 31 2009 17 28
36. F. Van de Werf Thrombin receptor antagonists may become an important antiplatelet therapy for coronary artery disease Eur Heart J 31 2010 2575 2576
37. J.M. Rox, J. Muller, and B. Potzsch PCR-Based amplification of platelet mRNA sequences obtained from small-scale platelet samples Methods Mol Biol 496 2009 285 292
38. L.A. Erickson, M.H. Ginsberg, and D.J. Loskutoff Detection and partial characterization of an inhibitor of plasminogen activator in human platelets J Clin Invest 74 1984 1465 1472
39. E. Sancho, P.J. Declerck, N.C. Price, S.M. Kelly, and N.A. Booth Conformational studies on plasminogen activator inhibitor (PAI-1) in active, latent, substrate, and cleaved forms Biochemistry 34 1995 1064 1069
40. R.R. Schleef, M. Sinha, and D.J. Loskutoff Immunoradiometric assay to measure the binding of a specific inhibitor to tissue-type plasminogen activator J Lab Clin Med 106 1985 408 415
41. N.A. Booth, A.J. Simpson, A. Croll, B. Bennett, and I.R. MacGregor Plasminogen activator inhibitor (PAI-1) in plasma and platelets Br J Haematol 70 1988 327 333
42. P. Mestdagh, T. Feys, N. Bernard, S. Guenther, C. Chen, and F. Speleman High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA Nucleic Acids Res 36 2008 e143
43. M. van Meijer, A. Smilde, G. Tans, M.E. Nesheim, H. Pannekoek, and A.J. Horrevoets The suicide substrate reaction between plasminogen activator inhibitor 1 and thrombin is regulated by the cofactors vitronectin and heparin Blood 90 1997 1874 1882
44. K. Bajou, H. Peng, W.E. Laug, C. Maillard, A. Noel, and J.M. Foidart Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis Cancer Cell 14 2008 324 334
45. L. Devy, S. Blacher, C. Grignet-Debrus, K. Bajou, V. Masson, and R.D. Gerard The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent FASEB J 16 2002 147 154
46. P.J. Declerck, M.C. Alessi, M. Verstreken, E.K. Kruithof, I. Juhan-Vague, and D. Collen Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay Blood 71 1988 220 225